Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties

Most of the marketed dry powder inhalation (DPI) products are traditional, carrier-based formulations with low drug concentrations deposited in the lung. However, due to their advantageous properties, their development has become justified. In our present work, we developed an innovative, carrier-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Benke, Edit, Farkas, Árpád, Szabó-Révész, Piroska, Ambrus, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356266/
https://www.ncbi.nlm.nih.gov/pubmed/32532040
http://dx.doi.org/10.3390/pharmaceutics12060535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356266/
https://www.ncbi.nlm.nih.gov/pubmed/32532040
http://dx.doi.org/10.3390/pharmaceutics12060535

Ejemplares similares